Henan Lingrui Pharmaceutical Co., Ltd. (SHA:600285)
China flag China · Delayed Price · Currency is CNY
22.56
-0.01 (-0.04%)
Apr 29, 2026, 3:00 PM CST

SHA:600285 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
452.89382.841,2281,4991,179801.24
Short-Term Investments
--283.0195.63125.34140.77
Trading Asset Securities
290.87160.35-0.21150.42280.19
Cash & Short-Term Investments
743.76543.21,5111,5951,4551,222
Cash Growth
-13.77%-64.06%-5.23%9.60%19.05%47.32%
Accounts Receivable
906.7713.34488.95498.99511.97431.18
Other Receivables
10.827.16.2919.3521.379.58
Receivables
917.52720.44495.23518.34533.34440.77
Inventory
392.61436.64434.97467.35486.41428.39
Other Current Assets
512.57579.6216.4518.5133.5839.87
Total Current Assets
2,5662,2802,4582,5992,5082,131
Property, Plant & Equipment
668.78682.62631.2647.81706.76732.92
Long-Term Investments
298.65298.591,4371,069676.63364.7
Goodwill
482.02482.02----
Other Intangible Assets
324.72330.14203.75202.5203.65236.95
Long-Term Deferred Tax Assets
217.7198.35199.59186.92159.2116.49
Long-Term Deferred Charges
17.3418.5412.3436.7351.5465.53
Other Long-Term Assets
1,3901,34574.4529.9838.45145.25
Total Assets
5,9665,6365,0174,7724,3453,793
Accounts Payable
102.5897.2785.1357.3868.0278.01
Accrued Expenses
159.86159.841,1761,110917.79600.38
Short-Term Debt
274.63391.6590.47199.94151.15272.34
Current Portion of Long-Term Debt
1.812.59----
Current Portion of Leases
--1.781.081.221.65
Current Income Taxes Payable
135.3372.6156.2870.7255.5446.9
Current Unearned Revenue
71.8883.64114.28114.48153.7579.09
Other Current Liabilities
1,4451,308350.24346.95364.47359.28
Total Current Liabilities
2,1912,1161,8741,9001,7121,438
Long-Term Leases
4.564.276.556.966.27.9
Long-Term Unearned Revenue
36.943133.439.7838.5542.78
Long-Term Deferred Tax Liabilities
47.6448.7422.2726.3229.5618.18
Total Liabilities
2,2802,2001,9371,9731,7861,507
Common Stock
567.12567.12567.12567.14567.46567.76
Additional Paid-In Capital
369.24367.2340.61326.23309.82272.02
Retained Earnings
2,6852,4382,1811,8941,6641,481
Treasury Stock
-12.58-12.58-13.7-47.4-67.62-98.19
Comprehensive Income & Other
40.3240.41-2.025176.7456.08
Total Common Equity
3,6493,4013,0732,7912,5512,279
Minority Interest
36.4535.337.777.667.557.59
Shareholders' Equity
3,6853,4363,0802,7992,5582,287
Total Liabilities & Equity
5,9665,6365,0174,7724,3453,793
Total Debt
281398.5198.8207.99158.57281.89
Net Cash (Debt)
462.76144.681,4131,3871,296940.31
Net Cash Growth
-40.18%-89.76%1.86%6.96%37.88%41.69%
Net Cash Per Share
0.820.252.502.452.281.66
Filing Date Shares Outstanding
566.28566.13564.42563.94569.61564.55
Total Common Shares Outstanding
566.28566.13564.42563.94569.61564.55
Working Capital
375.24164.31583.7698.77796.44693.59
Book Value Per Share
6.446.015.444.954.484.04
Tangible Book Value
2,8422,5882,8692,5892,3472,042
Tangible Book Value Per Share
5.024.575.084.594.123.62
Buildings
--588.03593.96595.01582.83
Machinery
--591.9581.63581.92534.7
Construction In Progress
--34.22.881.9224.78
Source: S&P Global Market Intelligence. Standard template. Financial Sources.